Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-06-08
DOI
10.1038/srep27367
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased cholesterol efflux capacity in metabolic syndrome: Relation with qualitative alterations in HDL and LCAT
- (2015) Diego Lucero et al. ATHEROSCLEROSIS
- HDL Cholesterol Efflux Predicts Graft Failure in Renal Transplant Recipients
- (2015) W. Annema et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The Association Between Reduction in Inflammation and Changes in Lipoprotein Levels and HDL Cholesterol Efflux Capacity in Rheumatoid Arthritis
- (2015) K. P. Liao et al. Journal of the American Heart Association
- Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study
- (2015) Danish Saleheen et al. Lancet Diabetes & Endocrinology
- Iron metabolism is prospectively associated with insulin resistance and glucose intolerance over a 7-year follow-up period: the CODAM study
- (2014) Nick Wlazlo et al. ACTA DIABETOLOGICA
- Effects of Native and Myeloperoxidase-Modified Apolipoprotein A-I on Reverse Cholesterol Transport and Atherosclerosis in Mice
- (2014) Bernd Hewing et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Regulation of ATP-binding Cassette Transporters and Cholesterol Efflux by Glucose in Primary Human Monocytes and Murine Bone Marrow-derived Macrophages
- (2014) N. Spartano et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Enhanced cholesterol efflux to HDL through the ABCA1 transporter in hypertriglyceridemia of type 2 diabetes
- (2014) Hussein N. Yassine et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
- (2014) Anand Rohatgi et al. NEW ENGLAND JOURNAL OF MEDICINE
- The cross-sectional association between uric acid and atherosclerosis and the role of low-grade inflammation: the CODAM study
- (2014) José M. A. Wijnands et al. RHEUMATOLOGY
- Distinct associations of complement C3a and its precursor C3 with atherosclerosis and cardiovascular disease
- (2014) Marleen M. van Greevenbroek et al. THROMBOSIS AND HAEMOSTASIS
- Importance of Evaluating Cell Cholesterol Influx With Efflux in Determining the Impact of Human Serum on Cholesterol Metabolism and Atherosclerosis
- (2013) Ginny L. Weibel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Impact of serum amyloid A on cellular cholesterol efflux to serum in type 2 diabetes mellitus
- (2013) J.G.S. Tsun et al. ATHEROSCLEROSIS
- Assessing the functional properties of high-density lipoproteins: an emerging concept in cardiovascular research
- (2013) Michela Triolo et al. Biomarkers in Medicine
- Low normal free T4 confers decreased high-density lipoprotein antioxidative functionality in the context of hyperglycaemia
- (2013) Michela Triolo et al. CLINICAL ENDOCRINOLOGY
- Simvastatin and bezafibrate increase cholesterol efflux in men with type 2 diabetes
- (2013) Michela Triolo et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Cardioprotective functions of HDLs
- (2013) Kerry-Anne Rye et al. JOURNAL OF LIPID RESEARCH
- The inverse relation of HDL anti-oxidative functionality with serum amyloid a is lost in metabolic syndrome subjects
- (2013) Robin P. F. Dullaart et al. Obesity
- Metabolic Syndrome, Insulin Resistance, and Roles of Inflammation – Mechanisms and Therapeutic Targets
- (2012) Giulio R. Romeo et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Pancreatic β-cell function relates positively to HDL functionality in well-controlled Type 2 diabetes mellitus
- (2012) Robin P.F. Dullaart et al. ATHEROSCLEROSIS
- High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A
- (2012) Markus Tölle et al. CARDIOVASCULAR RESEARCH
- Cholesterol Efflux and Atheroprotection
- (2012) Robert S. Rosenson et al. CIRCULATION
- Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes
- (2012) Hiroshi Murakami et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Advanced glycation end-products (AGEs) and functionality of reverse cholesterol transport in patients with type 2 diabetes and in mouse models
- (2012) H. Low et al. DIABETOLOGIA
- Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies
- (2012) Wijtske Annema et al. Nutrition & Metabolism
- Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL
- (2011) Paul J. W. H. Kappelle et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Cholesterol efflux from macrophages is influenced differentially by plasmas from overweight insulin-sensitive and -resistant subjects
- (2011) P Nestel et al. INTERNATIONAL JOURNAL OF OBESITY
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
- (2011) Amit V. Khera et al. NEW ENGLAND JOURNAL OF MEDICINE
- Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A2
- (2010) Wijtske Annema et al. JOURNAL OF LIPID RESEARCH
- High glucose stimulates macrophage SR-BI expression and induces a switch in its activity from cholesterol efflux to cholesterol influx
- (2009) Anna Gantman et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- HDL as a Biomarker, Potential Therapeutic Target, and Therapy: FIG. 1.
- (2009) Mohamad Navab et al. DIABETES
- Impaired serum capacity to induce cholesterol efflux is associated with endothelial dysfunction in type 2 diabetes mellitus
- (2009) Huali Zhou et al. Diabetes & Vascular Disease Research
- Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study
- (2009) M. Jacobs et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol
- (2008) Robin P F Dullaart et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies
- (2008) Theodore Mazzone et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now